関連する実験動画

Updated: Oct 2, 2026

In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers
13:10

In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers

Published on: August 1, 2014

10.8K

"抗体媒介による心臓拒絶の識別と分類のための遺伝子発現プロファイリング"に関する手紙に対するLoupy等による回答

Alexandre Loupy1, Luis Hidalgo1, Jean Paul Duong1

  • 1From Paris Translational Research Centre for Organ Transplantation, INSERM, UMR-S970, France (A.L., L.H., J.P.D.); Paris Descartes University and Hôpital Necker, Assistance Publique - Hôpitaux de Paris, France (A.L., L.H., J.P.D., P.B.); Alberta Transplant Applied Genomics Centre; University of Alberta, Edmonton, Canada (P.F.H.); and Cardiology Department and Intensive Care, Georges Pompidou Hospital, Paris, France (X.J.).

Circulation
|August 16, 2017
PubMed
まとめ

No abstract available in PubMed .

さらに関連する動画

Isolation and Identification of Extravascular Immune Cells of the Heart08:24

Isolation and Identification of Extravascular Immune Cells of the Heart

Published on: August 23, 2018

13.1K
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

2.4K

関連する概念動画

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...